The American Congress of obstetricians and Gynecologists (ACoG) estimates that 7% of pregnancies are complicated by some type of diabetes. Close to 90% of these cases are women with gestational diabetes (Gdm), as opposed to preexisting type 1 or type 2 diabetes. over the past few decades, the prevalence of both type 2 diabetes and Gdm has steadily increased, possibly related to the increasing obesity rate worldwide.
Uncontrolled diabetes during pregnancy can lead to a number of risks for both the mother and fetus, including spontaneous abortion, fetal anomalies, preeclampsia, macrosomia, neonatal hypoglycemia, and neonatal hyperbilirubinemia. early in pregnancy, insulin sensitivity is heightened, leading to lower blood glucose levels. As pregnancy progresses to the second and third trimesters, this effect is reversed, and insulin resistance becomes predominant. in women without diabetes, the pancreas is able to produce enough insulin to overcome the insulin resistance; 
Goals of Care
Pregnancy is associated with an increased rate of red blood cell turnover; therefore, during pregnancy, A1C goals are slightly lower than in non-pregnant patients. All 3 organizations recommend an A1C goal of 6% to 6.5% for (Table 1) . These intense glycemic targets often require patients to obtain selfmonitored blood glucose levels at least 4 times daily to capture fasting blood glucose and postprandial levels after each meal. None of the guidelines make a preference for a specific type of insulin to be used but if glyburide is prescribed, the recommended dosing range is 2.5 to 20 mg in a single or divided dose.
Treatment of GDM

Nonpharmacologic Options
Treatment of Preexisting Diabetes
in women with preexisting diabetes, insulin is also the preferred pharmacologic agent. 
